Non categorizzato Sanofi to acquire Provention Bio for $2.9 billion Marzo 13, 2023 0 commenti Sanofi SA announced Monday that it reached an agreement with US biopharmaceutical company Provention Bio, Inc to acquire it for $25 per share in cash, a deal worth approximately $2.9 billion. Prevent… About the author:
Get involved!
Comments